期刊文献+

小儿心肌病分类的建议和说明 被引量:5

原文传递
导出
摘要 小儿心肌病的正确分类对诊断、治疗、病情了解有重要作用。由于心肌病是异质性疾病,因此,分类容易有顾此失彼,不能同时满足临床和研究工作的需要。自1995年以来,有世界卫生组织(WHO)/国际心脏病协会(ISFC)、美国心脏病协会(AHA)、欧洲心脏病协会(ESC)。3个学术团体和2个个人制订的分类方案,其间差异很大。我国内科和儿科心血管专业尚未制订心肌病分类方案。为此,作者提出了一个以临床工作需要为主,符合我国国情和小儿特点的分类方案,经征求部分有关专家和从事儿科心血管专业的临床医生的意见,对争议较多的问题作了说明。现将小儿心肌病分类建议如下。
作者 马沛然 汪翼
出处 《中华儿科杂志》 CAS CSCD 北大核心 2012年第6期472-474,共3页 Chinese Journal of Pediatrics
  • 相关文献

参考文献13

  • 1Richardson P, McKenna W, Bristow M, et al. Report of the 1995 WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation, 1996, 93: $41-842.
  • 2Maron B J, Towbin JA, Thienne G, et al. Contemporary definition and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and councilon epidemiology and prevention. Circulation, 2006, 113: 1807- 1816.
  • 3Elliott P, Anderson B, Arbustini E, et al. Classification of the cardiomyopathies : a position statement from the european society of cardiology working group on myocardial and pericardial diseas. Eur Heart J, 2008, 29: 270-276.
  • 4Thienne G, Angelini A, Basso C, et al. The new definition and classification of cardiomyopathies. Adv Clin Path, 2000, 4: 53- 57.
  • 5Colan SD. Classification of the cardiomyopathies. Prog Pediatr Cardiol, 2007, 23: 5-15.
  • 6心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:550
  • 7E11iott P. The 2006 American Heart Association classification of cardiomyopathies is not the gold standard. Circ Heart Fail,2008, 1:77-80.
  • 8马沛然,汪翼,伊迎春.儿童心肌病定义与分类的现状和争议[J].中华儿科杂志,2010,48(12):892-895. 被引量:1
  • 9李文,马沛然,汪翼,韩秀珍,王玉林.扩张型心肌病患儿线粒体DNA点突变研究[J].实用儿科临床杂志,2001,16(1):1-2. 被引量:7
  • 10Colan SD, Lipshuhz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation, 2007, 115: 773-781.

二级参考文献74

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:59
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4廖玉华.从心肌病病因学研究走向临床诊断与治疗实践[J].中华心血管病杂志,2007,35(1):1-2. 被引量:26
  • 5九省市心肌炎协作组.小儿原发性心肌病诊断依据[J].中华儿科杂志,1981,19:62-62.
  • 6Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 7Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
  • 8Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58.
  • 9Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5.
  • 10McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58.

共引文献554

同被引文献38

  • 1项如莲,陈其,徐强,吴蓉洲,张琦,李焕斌.^(99)Tc^m和^(67)Ga心肌显像在小儿病毒性心肌炎中的应用[J].中华核医学杂志,2004,24(5):284-287. 被引量:13
  • 2宋文忠,姜荣建,黄劲,陈明曦,唐英容,谢红军,刘世俊,周爱群.病毒性心肌炎^(99)Tc^m-MIBI SPECT显像随访分析[J].中华核医学杂志,2005,25(4):221-221. 被引量:2
  • 3Maron BJ,Towbin JA,Thiene G, et al. Contemporary defini-tions and classification of the cardiomyopathies [ J]. Circulation,2006,113:1807-1816.
  • 4Elliott P, Andersson B, Arbustini E, et al. Classification of thecardiomyopathies: a position statement from the European Soci-ety Of Cardiology Working Group on Myocardial and PericardialDiseases [ J]. Eur Heart J,2008,29 : 270-276.
  • 5Wojniez R,Nowalany-Kozielska E,Wojciechowska C,et al.Randomized, placebo-controlled study for immunosuppressivetreatment of inflammatory dilated cardiomyopathy : two-year fol-low-up results [j]. Circulation, 2001,104: 39-45.
  • 6Richardson P, McKenna RW,Bristow M, et al. Report of the1995 World Health Organization/International Society and Fed-eration of Cardiology Task Force on the definition and classifica-tion of cardiomyopathies [j]. Circulation, 1996,93:841-842.
  • 7Maisch B, Richter A, Sandmoller A, et al. Inflammatory dilat-ed cardiomyopathy (DCMI) [J]. Herz ,2005,30:535-544.
  • 8Maisch B, Portig I,Ristic A,et al. Definition of inflammatorycardiomyopathy (myocarditis) : on the way to consensus - a sta-tus report [j]. Herz,2000,25 : 200-209.
  • 9Maisch B. World Heart Federation consensus conferences7 defi-nition of inflammatory cardiomyopathy (myocarditis) : reportfrom two expert committees on histology and viral cardiomyopa-thy[j]. Heart Beat, 1999,4:3-4.
  • 10Andreoletti I,Burlet T,Moukassa D,et al. Entervirseo can pesci-et with or without active viral replication on cardiac tissue of pa-tients with end-stage ischemic or dilated cardiomyopathy [j]. JInfect Dis,2000,182:1222-1227.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部